​

Boston Scientific (BSX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BSX Stock Forecast

Boston Scientific (BSX) stock forecast, based on 41 Wall Street analysts, predicts a 12-month average price target of $117.20, with a high of $130.00 and a low of $100.00. This represents a 18.91% increase from the last price of $98.56.

$35 $54 $73 $92 $111 $130 High: $130 Avg: $117.2 Low: $100 Last Closed Price: $98.56

BSX Stock Rating

Boston Scientific stock's rating consensus is Buy, based on 41 Wall Street analysts. The breakdown includes 2 Strong Buy (4.88%), 36 Buy (87.80%), 3 Hold (7.32%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 41 0 3 36 2 Strong Sell Sell Hold Buy Strong Buy

BSX Price Target Upside V Benchmarks

TypeNameUpside
StockBoston Scientific18.91%
SectorHealthcare Stocks 24.81%
IndustryMedical Device Stocks16.21%

Price Target Trends

1M3M12M
# Anlaysts-216
Avg Price Target-$120.50$100.50
Last Closing Price$98.56$98.56$98.56
Upside/Downside-22.26%1.97%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 258233--34
May, 257234--34
Apr, 256234-134
Mar, 256234-134
Feb, 257213-132
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 24, 2025Richard NewitterTruist Financial$117.00$100.5516.36%18.71%
Feb 18, 2025Argus Research$130.00$105.3523.40%31.90%
Feb 03, 2025Matt O'BrienPiper Sandler$115.00$103.0711.57%16.68%
Jan 02, 2025Vijay KumarEvercore ISI$100.00$89.3811.88%1.46%
Dec 30, 2024Marie ThibaultBTIG$101.00$89.6812.62%2.48%
Oct 24, 2024Shagun SinghRBC Capital$98.00$87.4512.06%-0.57%
Oct 24, 2024Kristen StewartC.L. King$90.00$87.452.92%-8.69%
Oct 21, 2024William PlovanicCanaccord Genuity$98.00$88.0711.28%-0.57%
Oct 18, 2024Rick WiseStifel Nicolaus$100.00$86.4215.71%1.46%
Oct 15, 2024David RescottRobert W. Baird$100.00$87.5514.22%1.46%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 22, 2025CitigroupBuyBuyhold
Apr 23, 2025BTIGBuyBuyhold
Apr 18, 2025CitigroupOutperformOutperformhold
Apr 16, 2025NeedhamHoldBuyupgrade
Feb 03, 2025Cowen & Co.BuyBuyhold
Feb 03, 2025Piper SandlerOverweightOverweighthold
Jan 10, 2025Deutsche BankHoldBuyupgrade
Jan 08, 2025BernsteinOutperformOutperformhold
Jan 02, 2025Evercore ISIOutperformOutperformhold
Dec 30, 2024BTIGBuyBuyhold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.10$0.69$0.45$1.08$1.26----
Avg Forecast$1.04$1.61$1.73$2.01$2.47$2.81$3.20$3.56$3.96
High Forecast$1.07$1.65$1.78$2.02$2.48$2.86$3.93$4.46$4.08
Low Forecast$1.03$1.59$1.68$2.00$2.46$2.76$2.46$2.61$3.80
Surprise %-109.62%-57.14%-73.99%-46.27%-48.99%----

Revenue Forecast

$5B $10B $15B $20B $25B $30B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$9.91B$11.89B$12.68B$14.24B$16.75B----
Avg Forecast$10.03B$11.87B$12.68B$14.12B$16.61B$18.79B$20.70B$22.61B$24.63B
High Forecast$10.21B$12.08B$12.97B$14.13B$16.68B$19.18B$20.70B$22.67B$25.22B
Low Forecast$9.91B$11.73B$12.36B$14.08B$16.54B$18.30B$20.70B$22.54B$23.83B
Surprise %-1.15%0.12%-0.02%0.88%0.83%----

Net Income Forecast

$-500M $1B $3B $4B $6B $7B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-140.00M$1.04B$698.00M$1.59B$1.85B----
Avg Forecast$1.53B$947.28M$909.12M$1.57B$3.61B$4.11B$4.68B$3.93B$5.80B
High Forecast$1.56B$1.14B$1.09B$1.88B$3.62B$4.19B$5.76B$6.52B$5.98B
Low Forecast$1.50B$757.83M$727.30M$1.26B$3.59B$4.04B$3.60B$3.81B$5.55B
Surprise %-109.16%9.89%-23.22%1.46%-48.65%----

BSX Forecast FAQ

Is Boston Scientific stock a buy?

Boston Scientific stock has a consensus rating of Buy, based on 41 Wall Street analysts. The rating breakdown includes 2 Strong Buy, 36 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Boston Scientific is a favorable investment for most analysts.

What is Boston Scientific's price target?

Boston Scientific's price target, set by 41 Wall Street analysts, averages $117.2 over the next 12 months. The price target range spans from $100 at the low end to $130 at the high end, suggesting a potential 18.91% change from the previous closing price of $98.56.

How does Boston Scientific stock forecast compare to its benchmarks?

Boston Scientific's stock forecast shows a 18.91% upside, underperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the medical device stocks industry (16.21%).

What is the breakdown of analyst ratings for Boston Scientific over the past three months?

  • June 2025: 23.53% Strong Buy, 67.65% Buy, 8.82% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 20.59% Strong Buy, 67.65% Buy, 11.76% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 17.65% Strong Buy, 67.65% Buy, 11.76% Hold, 0% Sell, 2.94% Strong Sell.

What is Boston Scientific’s EPS forecast?

Boston Scientific's average annual EPS forecast for its fiscal year ending in December 2025 is $2.81, marking a 123.02% increase from the reported $1.26 in 2024. Estimates for the following years are $3.2 in 2026, $3.56 in 2027, and $3.96 in 2028.

What is Boston Scientific’s revenue forecast?

Boston Scientific's average annual revenue forecast for its fiscal year ending in December 2025 is $18.79B, reflecting a 12.21% increase from the reported $16.75B in 2024. The forecast for 2026 is $20.7B, followed by $22.61B for 2027, and $24.63B for 2028.

What is Boston Scientific’s net income forecast?

Boston Scientific's net income forecast for the fiscal year ending in December 2025 stands at $4.11B, representing an 121.97% increase from the reported $1.85B in 2024. Projections indicate $4.68B in 2026, $3.93B in 2027, and $5.8B in 2028.